Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.

Plasma glucose and insulin responses to a graded i.v. infusion of glucose were compared in two groups of glucose-tolerant women divided on the basis of their insulin sensitivity. Resistance to insulin-mediated glucose disposal was measured using the insulin suppression test, and the women studied were chosen to represent the highest and lowest quartiles of insulin resistance seen in the normal population. The sensitivity of the pancreatic beta-cell to glucose was assessed by measuring the glucose, insulin, and C peptide concentrations in response to continuous graded i.v. infusions of glucose at rates of 1, 2, 3, 4, 6, and 8 mg/kg x min for 40 min each. In addition, insulin secretion rates in response to the graded glucose infusion, calculated over each sampling period, were derived from deconvolution of peripheral plasma C peptide concentrations, using a two-compartment model of C peptide kinetics and standard parameters for C peptide clearance. Although plasma glucose concentrations were only slightly higher throughout the glucose infusion, the insulin concentrations were approximately doubled in the insulin-resistant subjects. When expressed as a function of the molar increments in plasma glucose achieved during the glucose infusion studies, the insulin-resistant women had a 90% higher (684 +/- 55 vs. 360 +/- 36 pmol/L x mmol/L; P < 0.001) total integrated plasma insulin response as the glucose concentration was increased from 5 to 9 mmol/L. However, the total integrated insulin secretory rate was only increased by 37% (1494 +/- 133 vs. 1093 +/- 125 pmol/mmol/L x min; P < 0.05) in the insulin-resistant group. This discrepancy suggested that insulin clearance was lower in the insulin-resistant subjects, and the calculation of this value, as the ratio of the total secretion of insulin to the area under the plasma insulin curve, was significantly lower in the insulin-resistant group (1.25 +/- 0.05 vs. 1.87 +/- 0.16 L/min x m2; P < 0.005). These results show that the hyperinsulinemia of insulin resistance results from an increase in insulin secretion secondary to a shift to the left of the glucose-stimulated insulin response curve as well as a decrease in insulin clearance.

[1]  R. DeFronzo,et al.  Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. , 1983, The American journal of physiology.

[2]  H. Galbo,et al.  Effects of training and detraining on dose-response relationship between glucose and insulin secretion. , 1989, The American journal of physiology.

[3]  B H Frank,et al.  Quantitative study of insulin secretion and clearance in normal and obese subjects. , 1988, The Journal of clinical investigation.

[4]  R. Bergman,et al.  Relationship of insulin clearance and secretion to insulin sensitivity in non‐diabetic Mexican Americans , 1992, European journal of clinical investigation.

[5]  Y. Ida Chen,et al.  Insulin Resistance and Insulin Secretion Are Determinants of Oral Glucose Tolerance in Normal Individuals , 1993, Diabetes.

[6]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[7]  E. Ferrannini,et al.  INSULIN KINETICS AFTER PORTAL AND PERIPHERAL INJECTION OF [INSULIN[I-125] .1. DATA-ANALYSIS AND MODELING , 1976 .

[8]  G. Reaven,et al.  Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. , 1970, The Journal of clinical investigation.

[9]  P. Felig,et al.  Influence of physical training on insulin release and glucose utilization by islet cells and liver glucokinase activity in the rat. , 1982, The American journal of physiology.

[10]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[11]  S. Margolis,et al.  Hyperinsulinemia of obesity is due to decreased clearance of insulin. , 1983, The American journal of physiology.

[12]  Bruce H. Frank,et al.  Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. , 1986, The Journal of clinical investigation.

[13]  P. J. Randle,et al.  Immunoassay of insulin with insulin antibody preciptate. , 1963, Lancet.

[14]  K. Clément,et al.  Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. , 1994, The Journal of clinical investigation.

[15]  G. Reaven,et al.  Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. , 1987, The Journal of clinical endocrinology and metabolism.

[16]  C. Östenson,et al.  Physical fitness and insulin sensitivity in human subjects with a low insulin response to glucose. , 1994, Clinical science.

[17]  P. J. Randle,et al.  Immunoassay of insulin with insulin-antibody precipitate. , 1963, The Biochemical journal.

[18]  J. Sternberg,et al.  A New and Rapid Method for the Determination of Glucose by Measurement of Rate of Oxygen Consumption , 1968 .

[19]  U. Keller [Classification and diagnosis of diabetes mellitus]. , 1986, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis.

[20]  D. Schuster,et al.  Ethnic Differences in Secretion, Sensitivity, and Hepatic Extraction of Insulin in Black and White Americans , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[21]  G. Reaven,et al.  Relationship Between the Plasma Insulin Response to Oral Glucose and Insulin-stimulated Glucose Utilization in Normal Subjects , 1984, Diabetes.

[22]  M. Byrne,et al.  Insulin secretion and clearance during low-dose graded glucose infusion. , 1995, The American journal of physiology.

[23]  M. Haneda,et al.  Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. , 1978, Metabolism: clinical and experimental.

[24]  R. Torella,et al.  Hyperinsulinemia in offspring of non-insulin-dependent diabetes mellitus patients: the role played by abnormal clearance of insulin. , 1995, Metabolism: clinical and experimental.